Site Search
Results
-
Minutes: BSC; June 8, 2021
Counselors cART Combined antiretroviral therapies CEM Combined Exposures and Mixtures CPSC ... Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) therapies ...
Size: 1.3MB https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/bsc/2021/june/minutesbsc20210608_508.pdf -
RoC Profile: Chlorambucil; 15th RoC 2021
Numerous case reports have linked treatment with chlorambucil, ei- ther alone or in combination with other therapies, with development of cancer, primarily acute nonlymphocytic ...
Size: 121KB https://ntp.niehs.nih.gov/sites/default/files/ntp/roc/content/profiles/chlorambucil.pdf -
Novel Alternative Methods (NAMs) Validation and Qualification...
advance research that will lead to new therapies, diagnostics, and potential cures ... We accelerate prevention, new therapies, diagnostics & potential cures We advance global ...
Size: 3.7MB https://ntp.niehs.nih.gov/sites/default/files/2024-10/2-6_Adam_SACATM2024_508.pdf -
Agenda: Draft Monograph on Developmental Effects and Pregnancy...
Topoisomerase II Inhibitor Oxygen-free Radical Generator Targeted Therapies Presentation on each mechanism Peer review comments on each agent Panel discussion on each agent Dr. ...
Size: 56KB https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/monopeerrvw/2012/october/agenda20121002_508.pdf -
Minutes: MPRP; Oct. 1-2, 2012
......... 31 F. Targeted Therapies ......topoisomerase II inhibitors/oxygen free radical generators, and targeted therapies. ...
Size: 559KB https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/monopeerrvw/2012/october/minutes20121002_508.pdf -
ICCVAM Public Forum: May 2023
Measurement Science in ICCVAM: Elijah Petersen, NIST In Vitro Co-Culture Assays to Assess Safety of CAR-T Cell Therapies: Shari Price, Leidos Biomedical Research (contractor ...
https://ntp.niehs.nih.gov/whatwestudy/niceatm/3rs-meetings/past-meetings/pubforum-2023/iccvamforum-2023 -
FDA Guidance: Instructions and Template for Chemistry, Manufacturing...
Office of Cellular, Tissue, and Gene Therapies at 301-827-5102. U.S. Department of ... In order to deliver a safe and effective product, human somatic cell therapies present ...
Size: 338KB https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/fda/fda_cmcsomcell.pdf -
FDA Guidance: Content and Review of Chemistry, Manufacturing...
Office of Cellular, Tissue, and Gene Therapies at 301-827-5102. U.S. Department of ... In order to deliver a safe and effective product, human gene therapies present many ...
Size: 400KB https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/fda/fda_gtindcmc.pdf -
FNIH Overview for ICCVAM (ICCVAM 2024 Public Forum)
advance research that will lead to new therapies, diagnostics, and potential cures. 4 ... We advance global health & seek equity in care We accelerate prevention, new therapies, ...
Size: 4.8MB https://ntp.niehs.nih.gov/sites/default/files/2024-06/14_Conners_ICCVAMPublicForum2024_508.pdf -
Regulatory Applications of 3Rs
The U.S. Food and Drug Administration (FDA) has announced a plan to replace animal testing in the development of monoclonal antibody therapies and other drugs with more effective, ...
https://ntp.niehs.nih.gov/whatwestudy/niceatm/accept-methods/apps
to Top